115 related articles for article (PubMed ID: 38631651)
21. MicroRNA-379 inhibits cell proliferation and invasion in glioma via targeting metadherin and regulating PTEN/AKT pathway.
Li L; Zhang H
Mol Med Rep; 2018 Mar; 17(3):4049-4056. PubMed ID: 29286115
[TBL] [Abstract][Full Text] [Related]
22. LncRNA BCYRN1 inhibits glioma tumorigenesis by competitively binding with miR-619-5p to regulate CUEDC2 expression and the PTEN/AKT/p21 pathway.
Mu M; Niu W; Zhang X; Hu S; Niu C
Oncogene; 2020 Nov; 39(45):6879-6892. PubMed ID: 32978519
[TBL] [Abstract][Full Text] [Related]
23. SHP-2-upregulated ZEB1 is important for PDGFRα-driven glioma epithelial-mesenchymal transition and invasion in mice and humans.
Zhang L; Zhang W; Li Y; Alvarez A; Li Z; Wang Y; Song L; Lv D; Nakano I; Hu B; Cheng SY; Feng H
Oncogene; 2016 Oct; 35(43):5641-5652. PubMed ID: 27041571
[TBL] [Abstract][Full Text] [Related]
24. Cyr61 mediates hepatocyte growth factor-dependent tumor cell growth, migration, and Akt activation.
Goodwin CR; Lal B; Zhou X; Ho S; Xia S; Taeger A; Murray J; Laterra J
Cancer Res; 2010 Apr; 70(7):2932-41. PubMed ID: 20233866
[TBL] [Abstract][Full Text] [Related]
25. miR-489 inhibits proliferation, cell cycle progression and induces apoptosis of glioma cells via targeting SPIN1-mediated PI3K/AKT pathway.
Li Y; Ma X; Wang Y; Li G
Biomed Pharmacother; 2017 Sep; 93():435-443. PubMed ID: 28666210
[TBL] [Abstract][Full Text] [Related]
26. Akt-mTOR signaling is involved in Notch-1-mediated glioma cell survival and proliferation.
Zhao N; Guo Y; Zhang M; Lin L; Zheng Z
Oncol Rep; 2010 May; 23(5):1443-7. PubMed ID: 20372862
[TBL] [Abstract][Full Text] [Related]
27. TRPV4 promotes the migration and invasion of glioma cells via AKT/Rac1 signaling.
Ou-Yang Q; Li B; Xu M; Liang H
Biochem Biophys Res Commun; 2018 Sep; 503(2):876-881. PubMed ID: 29928875
[TBL] [Abstract][Full Text] [Related]
28. MiR-24 Promotes Cell Growth in Human Glioma by
Lei D; Sun H; Zhang B
Cancer Biother Radiopharm; 2021 Sep; 36(7):588-599. PubMed ID: 32876500
[TBL] [Abstract][Full Text] [Related]
29. Molecular mechanisms of activation of endothelial nitric oxide synthase mediated by transient receptor potential vanilloid type 1.
Ching LC; Kou YR; Shyue SK; Su KH; Wei J; Cheng LC; Yu YB; Pan CC; Lee TS
Cardiovasc Res; 2011 Aug; 91(3):492-501. PubMed ID: 21493704
[TBL] [Abstract][Full Text] [Related]
30. Cannabidiol stimulates Aml-1a-dependent glial differentiation and inhibits glioma stem-like cells proliferation by inducing autophagy in a TRPV2-dependent manner.
Nabissi M; Morelli MB; Amantini C; Liberati S; Santoni M; Ricci-Vitiani L; Pallini R; Santoni G
Int J Cancer; 2015 Oct; 137(8):1855-69. PubMed ID: 25903924
[TBL] [Abstract][Full Text] [Related]
31. MAGI3 Suppresses Glioma Cell Proliferation via Upregulation of PTEN Expression.
Ma Q; Zhang Y; Meng R; Xie KM; Xiong Y; Lin S; He ZL; Tao T; Yang Y; Zhao JZ; He JQ
Biomed Environ Sci; 2015 Jul; 28(7):502-9. PubMed ID: 26248734
[TBL] [Abstract][Full Text] [Related]
32. Overexpressed transient receptor potential vanilloid 1 (TRPV1) in lung adenocarcinoma harbours a new opportunity for therapeutic targeting.
Nie Y; Feng F; Luo W; Sanders AJ; Zhang Y; Liang J; Chen C; Feng W; Gu W; Liao W; Wang W; Chen J; Zhang L; Jiang WG; Li J
Cancer Gene Ther; 2022 Oct; 29(10):1405-1417. PubMed ID: 35354949
[TBL] [Abstract][Full Text] [Related]
33. Cross-talk between alpha1D-adrenoceptors and transient receptor potential vanilloid type 1 triggers prostate cancer cell proliferation.
Morelli MB; Amantini C; Nabissi M; Liberati S; Cardinali C; Farfariello V; Tomassoni D; Quaglia W; Piergentili A; Bonifazi A; Del Bello F; Santoni M; Mammana G; Servi L; Filosa A; Gismondi A; Santoni G
BMC Cancer; 2014 Dec; 14():921. PubMed ID: 25481381
[TBL] [Abstract][Full Text] [Related]
34. Bone marrow mesenchymal stem cells suppress growth and promote the apoptosis of glioma U251 cells through downregulation of the PI3K/AKT signaling pathway.
Lu L; Chen G; Yang J; Ma Z; Yang Y; Hu Y; Lu Y; Cao Z; Wang Y; Wang X
Biomed Pharmacother; 2019 Apr; 112():108625. PubMed ID: 30784920
[TBL] [Abstract][Full Text] [Related]
35. PTEN reconstitution alters glioma responses to c-Met pathway inhibition.
Goodwin CR; Lal B; Ho S; Woodard CL; Zhou X; Taeger A; Xia S; Laterra J
Anticancer Drugs; 2011 Oct; 22(9):905-12. PubMed ID: 21654317
[TBL] [Abstract][Full Text] [Related]
36. The TRPV4-AKT axis promotes oral squamous cell carcinoma cell proliferation via CaMKII activation.
Fujii S; Tajiri Y; Hasegawa K; Matsumoto S; Yoshimoto RU; Wada H; Kishida S; Kido MA; Yoshikawa H; Ozeki S; Kiyoshima T
Lab Invest; 2020 Feb; 100(2):311-323. PubMed ID: 31857698
[TBL] [Abstract][Full Text] [Related]
37. RNA-binding protein Musashi1 modulates glioma cell growth through the post-transcriptional regulation of Notch and PI3 kinase/Akt signaling pathways.
Muto J; Imai T; Ogawa D; Nishimoto Y; Okada Y; Mabuchi Y; Kawase T; Iwanami A; Mischel PS; Saya H; Yoshida K; Matsuzaki Y; Okano H
PLoS One; 2012; 7(3):e33431. PubMed ID: 22428049
[TBL] [Abstract][Full Text] [Related]
38. PTPN1 promotes the progression of glioma by activating the MAPK/ERK and PI3K/AKT pathways and is associated with poor patient survival.
Jin T; Li D; Yang T; Liu F; Kong J; Zhou Y
Oncol Rep; 2019 Aug; 42(2):717-725. PubMed ID: 31173266
[TBL] [Abstract][Full Text] [Related]
39. PSMB8 regulates glioma cell migration, proliferation, and apoptosis through modulating ERK1/2 and PI3K/AKT signaling pathways.
Yang BY; Song JW; Sun HZ; Xing JC; Yang ZH; Wei CY; Xu TY; Yu ZN; Zhang YN; Wang YF; Chang H; Xu ZP; Hou M; Ji MJ; Zhang YS
Biomed Pharmacother; 2018 Apr; 100():205-212. PubMed ID: 29428669
[TBL] [Abstract][Full Text] [Related]
40. BRCA1-associated protein inhibits glioma cell proliferation and migration and glioma stem cell self-renewal via the TGF-β/PI3K/AKT/mTOR signalling pathway.
Wang B; Cao C; Liu X; He X; Zhuang H; Wang D; Chen B
Cell Oncol (Dordr); 2020 Apr; 43(2):223-235. PubMed ID: 31776938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
